Anti-CD38 Pretargeted Radioimmunotherapy Eradicates Multiple Myeloma Xenografts In a Murine Model

被引：3
|
作者：
Green, Damian J.
Jones, Jon C.
Hylarides, Mark D.
Hamlin, Donald K.
Wilbur, D. Scott
Lin, Yukang
Kenoyer, Aimee L.
Frayo, Shani L.
Bensinger, William I.
Gopal, Ajay K.
Orozco, Johnnie J.
Gooley, Theodore A.
Wood, Brent L.
Pagel, John M.
Press, Oliver W.
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.882.882
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
882
引用
收藏
页数：2
相关论文
共 50 条
  • [21] SAR 650984, a Therapeutic Anti-CD38 Monoclonal Antibody, Blocks CD38-CD31 Interaction in Multiple Myeloma
    An, Gang
    Jiang, Hua
    Acharya, Chirag
    Zhong, Mike Y.
    Cai, Ti
    Yang, Guang
    Song, Zhili
    Theilhaber, Joachim
    Adrian, Francisco
    Tai, Yu-Tzu
    Anderson, Kenneth C.
    BLOOD, 2014, 124 (21)
  • [22] Analyzing Risk of Infection with Anti-CD38 Monoclonal Antibody Therapy for Patients with Multiple Myeloma
    Hong, Augustine
    Eduafo, Augusta
    Schmikla, Hannah
    Brown, George
    Ravi, Gayathri
    de Lima, Marcos
    Malek, Ehsan
    BLOOD, 2020, 136
  • [23] Anti-CD45 pretargeted radioimmunotherapy in a nonhuman primate model
    Green, Damian J.
    Pagel, John M.
    Nemecek, Eneida R.
    Pantelias, Anastasia
    Lin, Yukang
    Kenoyer, Aimee L.
    Fisher, Darrell R.
    Wilbur, D. S.
    Hamlin, Donald K.
    Gopal, Ajay K.
    Press, Oliver W.
    BLOOD, 2007, 110 (11) : 691A - 691A
  • [24] Comparison of Anti-CD38 Based Quadruplets As Induction Therapy for Newly Diagnosed Multiple Myeloma
    Kastritis, Efstathios
    Fotiou, Despina
    Theodorakakou, Foteini
    Solia, Irene
    Spiliopoulou, Vasiliki
    Ntanasis-Stathopoulos, Ioannis
    Malandrakis, Panagiotis
    Kanellias, Nikolaos
    Roussou, Maria
    Migkou, Magdalini
    Eleutherakis-Papaiakovou, Evangelos
    Terpos, Evangelos
    Gavriatopoulou, Maria
    Dimopoulos, Meletios
    BLOOD, 2024, 144 : 7021 - 7022
  • [25] EZH2 Targeting Induces CD38 Upregulation and Response to Anti-CD38 Antibodies in Multiple Myeloma
    Chemlal, Djamila
    Varlet, Emmanuel
    Machura, Amelie
    Requirand, Guilhem
    Robert, Nicolas
    Alaterre, Elina
    Vincent, Laure
    Herbaux, Charles
    Cavalli, Giacomo
    Bruyer, Angelique
    De Boussac, Hugues
    Moreaux, Jerome
    BLOOD, 2022, 140 : 4220 - 4221
  • [26] Pharmacy considerations: Use of anti-CD38 monoclonal antibodies in relapsed and/or refractory multiple myeloma
    Shah, Bhavesh
    Gray, Joy
    Abraham, Ivo
    Chang, Melody
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (01) : 170 - 182
  • [27] EZH2 targeting induces CD38 upregulation and response to anti-CD38 immunotherapies in multiple myeloma
    Chemlal, Djamila
    Varlet, Emmanuel
    Machura, Amelie
    Ovejero, Sara
    Requirand, Guilhem
    Robert, Nicolas
    Cartron, Guillaume
    Alaterre, Elina
    Bret, Caroline
    Vincent, Laure
    Herbaux, Charles
    Cavalli, Giacomo
    Bruyer, Angelique
    De Boussac, Hugues
    Moreaux, Jerome
    LEUKEMIA, 2023, 37 (9) : 1925 - 1928
  • [28] SURVIVAL IN PATIENTS WITH MULTIPLE MYELOMA (MM) REFRACTORY TO PROTEASOME INHIBITORS, IMMUNOMODULATORS, AND ANTI-CD38
    Gener Ricos, G.
    Abril Sabater, L.
    Ibarra Fernandez, G.
    Franch Sarto, M.
    Santos Gomez, M.
    Canamero Giro, E.
    Comes Escoda, M.
    Espasa Perez, A.
    De La Fuente Montes, C.
    Huguet Mas, M.
    Quintela Vilchez, D.
    Ribera-Santasusana, J. M.
    Oriol Rocafiguera, A.
    HAEMATOLOGICA, 2019, 104 : 9 - 10
  • [29] Case report: serological testing interference of daratumumab (anti-CD38) therapy in multiple myeloma
    Rabut, Elodie
    Castro-Fernandez, Annabelle
    Le Gall, Virginie
    Meknache, Nihad
    ANNALES DE BIOLOGIE CLINIQUE, 2017, 75 (03) : 351 - 355
  • [30] Clinical outcomes of Multiple Myeloma patients after anti-CD38 monoclonal antibodies failure
    Zamanillo, Irene
    De la Puerta, Rosalia
    Gil, Rodrigo
    Poza, Maria
    De la Puerta, Rodrigo
    Alonso, Rafael
    Cedena, Teresa
    Calbacho, Maria
    Ayala, Rosa
    Martinez-Lopez, Joaquin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S164 - S165
12345